Richard Paul Bryce - Net Worth and Insider Trading
Richard Paul Bryce Net Worth
The estimated net worth of Richard Paul Bryce is at least $390,535 dollars as of 2024-11-13. Richard Paul Bryce is the SEE REMARKS of Puma Biotechnology Inc and owns about 121,662 shares of Puma Biotechnology Inc (PBYI) stock worth over $390,535. Details can be seen in Richard Paul Bryce's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Paul Bryce has not made any transactions after 2021-04-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Paul Bryce
Richard Paul Bryce Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Paul Bryce owns 3 companies in total, including Puma Biotechnology Inc (PBYI) , Rain Oncology Inc (RAIN) , and enGene Holdings Inc (ENGN) .
Click here to see the complete history of Richard Paul Bryce’s form 4 insider trades.
Insider Ownership Summary of Richard Paul Bryce
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PBYI | Puma Biotechnology Inc | 2021-04-05 | SR VP & CLINICAL RESEARCH & DEV |
RAIN | Rain Oncology Inc | 2021-04-22 | Chief Medical Officer |
ENGN | enGene Holdings Inc | 2023-10-31 | Chief Medical Officer |
Richard Paul Bryce Latest Holdings Summary
Richard Paul Bryce currently owns a total of 1 stock. Richard Paul Bryce owns 121,662 shares of Puma Biotechnology Inc (PBYI) as of April 5, 2021, with a value of $390,535.
Latest Holdings of Richard Paul Bryce
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PBYI | Puma Biotechnology Inc | 2021-04-05 | 121,662 | 3.21 | 390,535 |
Holding Weightings of Richard Paul Bryce
Richard Paul Bryce Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Paul Bryce has made a total of 17 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Puma Biotechnology Inc is the sale of 426 shares on April 5, 2021, which brought Richard Paul Bryce around $4,175.
Insider Trading History of Richard Paul Bryce
- 1
Richard Paul Bryce Trading Performance
GuruFocus tracks the stock performance after each of Richard Paul Bryce's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Paul Bryce is -14.09%. GuruFocus also compares Richard Paul Bryce's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Paul Bryce within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Paul Bryce's insider trading performs compared to the benchmark.
Performance of Richard Paul Bryce
Richard Paul Bryce Ownership Network
Ownership Network List of Richard Paul Bryce
Ownership Network Relation of Richard Paul Bryce
Richard Paul Bryce Owned Company Details
What does Puma Biotechnology Inc do?
Who are the key executives at Puma Biotechnology Inc?
Richard Paul Bryce is the SR VP & CLINICAL RESEARCH & DEV of Puma Biotechnology Inc. Other key executives at Puma Biotechnology Inc include Chief Financial Officer Maximo F Nougues , Chief Commercial Officer Jeffrey Jerome Ludwig , and See Remarks Douglas M Hunt .
Puma Biotechnology Inc (PBYI) Insider Trades Summary
Over the past 18 months, Richard Paul Bryce made no insider transaction in Puma Biotechnology Inc (PBYI). Other recent insider transactions involving Puma Biotechnology Inc (PBYI) include a net sale of 142,899 shares made by Alan H Auerbach , a net sale of 39,813 shares made by Maximo F Nougues , and a net sale of 33,708 shares made by Jeffrey Jerome Ludwig .
In summary, during the past 3 months, insiders sold 0 shares of Puma Biotechnology Inc (PBYI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 510,451 shares of Puma Biotechnology Inc (PBYI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 510,451 shares.
Puma Biotechnology Inc (PBYI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Puma Biotechnology Inc Insider Transactions
Richard Paul Bryce Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Paul Bryce. You might contact Richard Paul Bryce via mailing address: C/o Puma Biotechnology, Inc., 10880 Wilshire Boulevard, Suite 2150, Los Angeles Ca 90024.